NEW YORK, June 17 (GenomeWeb News) - ProQinase, the NMI Natural and Medical Sciences Institute, and Antibodies by Design, all based in Germany, have received a three-year, €2 million ($2.45 million) grant from the German government to develop an adenoviral siRNA kinome chip, the partners said today.
The chip will enable scientists to inhibit all human protein kinases in parallel by RNA interference.
Under the collaboration, Antibodies by Design, a division of Munich-based MorphoSys, will generate recombinant antibodies against up to 250 protein kinases. NMI, a non-profit contractor based at the
NMI said it has filed for a patent protecting the production and use of the chip with the German Patent Office.